AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

SpectRx reports fourth quarter and year-end 2001 results.(Brief Article)(Statistical Data Included)

Women's Health Weekly

| April 04, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 APR 4 - (NewsRx.com & NewsRx.net) -- SpectRx, Inc., (SPRX) announced that product revenue for the fourth quarter of 2001 was $632,000, a 10% gain over the fourth quarter of 2000. This includes record sales of the company's single-use disposables for the BiliChek noninvasive bilirubin analyzer, which increased 139% over the fourth quarter of 2000.

Total revenues for the BiliChek product line grew 20% in the fourth quarter of 2001 compared with the fourth quarter of 2000. Sales for the quarter were 213 BiliChek devices and approximately 127,000 BiliCal disposables.

For the year ended December 31, 2001, BiliChek product revenues increased 18% to $2.2 million compared with 2000 revenues of $1.9 million. Unit sales for the year were 805 BiliChek devices and 403,410 disposables, an increase in disposable revenue of 101% over 2000.

The net loss for the fourth quarter of 2001 was $1.8 million, or $0.17 per share, compared with a net loss of $256,000, or $0.03 per share, in the comparable quarter of 2000. The fourth quarter of 2000 included a one-time $2.0 million milestone payment from Abbott Laboratories. For the full year, the net loss was $7.3 million, or $0.75 per share, compared with a net loss of $6.7 million, or $0.79 per share, in 2000. Revenue for 2000 included $2.7 million in one-time milestone payments.

The quarterly loss primarily resulted from research and development programs for the company's continuous glucose monitor and noninvasive cervical cancer detection device, as well as fees related to arbitration and other legal activities.

"The integration of Sterling Medivations into our diabetes business, announced in January, is proceeding smoothly and we believe we remain on track to launch our first product, which is trademarked 'Simple Choice,' in the third quarter of this year," said Mark A. Samuels, chairman and CEO of SpectRx. "Our pipeline of innovative insulin delivery products also continues to develop. The latest product ...

Related articles from newspapers, magazines, journals, and more
TheraSense Announces Fourth Quarter and Full-Year 2003 Financial Results;...
Press release article from: PR Newswire January 22, 2004 700+ words
...Gross margin for the fourth quarter of 2003 was 62% compared to 53% for the fourth quarter of 2002. The improved...for Navigator, our continuous glucose monitoring system...net income for the fourth quarter of 2003 was $4...
SpectRx Reports Third Quarter Results and Advances in its Continuous Glucose...
Press release article from: PR Newswire November 8, 2000 700+ words
...milestone payment in its continuous glucose monitoring program...the Company's continuous glucose monitor and non...share loss for the fourth quarter and a $0.96 loss...development milestone for continuous glucose monitoring. Assuming...
MiniMed Inc. Announces Record Second Quarter Sales and Earnings; Comments on...
Press release article from: PR Newswire July 22, 1998 700+ words
...clearance of the Company's continuous glucose sensor system. Following...status of our first generation continuous glucose monitoring product has been...sensor product during the fourth quarter of 1998, as has been our...
TheraSense Announces Fourth Quarter and Full Year 2002 Financial Results.
Press release article from: PR Newswire February 6, 2003 700+ words
...Gross margin for the fourth quarter of 2002 was 53% compared to 38% for the fourth quarter of 2001. The improved...further progress on our continuous glucose monitoring system." Net loss for the fourth quarter of 2002 was $5...
TheraSense announces fourth-quarter and full-year 2002 financial results.
Newspaper article from: Medical Devices & Surgical Technology Week March 9, 2003 700+ words
...Gross margin for the fourth quarter of 2002 was 53% compared to 38% for the fourth quarter of 2001. The improved...further progress on our continuous glucose monitoring system." Net loss for the fourth quarter of 2002 was $5...
MiniMed Inc. Announces FDA Panel Meeting For Continuous Glucose Monitoring...
Press release article from: PR Newswire December 23, 1998 700+ words
...for a system designed to provide continuous glucose monitoring for people with diabetes...has developed a minimally invasive continuous glucose monitoring system which provides...interstitial glucose levels. MiniMed's continuous glucose sensor is designed to be inserted...
MiniMed Inc. Announces Continuous Glucose Monitoring System Product Launch.
Press release article from: Business Wire July 26, 1999 700+ words
...commenced commercial distribution of its continuous glucose monitoring system for treating people...disposable sensor component. MiniMed's continuous glucose sensor is designed to be inserted...pumps and related disposables, a continuous glucose monitoring system product and the...
SpectRx, Inc. Proceeding with Development of Continuous Glucose Monitor.
Press release article from: PR Newswire January 10, 2003 700+ words
...initiated development work on its continuous glucose monitoring technology. SpectRx...of SpectRx's rights to the continuous glucose monitoring technology were returned. "We believe the continuous glucose monitoring technology, combined...
New Analytical Tool Developed to Evaluate the Accuracy of Continuous Glucose...
Press release article from: PR Newswire July 30, 2004 700+ words
...that a new analytical tool -- the Continuous Glucose Error-Grid Analysis (CG-EGA...evaluate the clinical accuracy of continuous glucose monitoring in people with diabetes...falling or remaining steady. "Continuous glucose sensor technology has the potential...
Study Shows Real-Time Continuous Glucose Monitoring Drives Informed Patient...
Press release article from: Business Wire June 11, 2005 700+ words
...using Medtronic's Guardian(R) RT Continuous Glucose Monitoring System presented at Annual...used Medtronic's Guardian(R) RT Continuous Glucose Monitoring System to monitor glucose...gleaning insights from real-time continuous glucose monitoring (CGM). In addition...
For more facts and information, see all results

Source: HighBeam Research, SpectRx reports fourth quarter and year-end 2001 results.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA